Internal Medicine, Infectious Disease · Lincoln, NE
NPI
1134498330
Since 2011
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 S 48th St Ste 506
Lincoln, NE, 68506
Phone (402) 489-1110
Groups this clinician bills Medicare through
Medicare paid, 2024
$130K
28,536 services
Medicare patients, 2024
517
Average age 74
Drug cost, 2024
$942K
1,588 prescriptions
Company payments, 2025
$20.76
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel T Smith was code 99232 (hospital e&m - subsequent), 998 times for 359 patients. In total Daniel T Smith billed 28,536 services in 35 codes, and Medicare paid $130K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 998 | 359 | $56.94 | $57K |
| 99223 Hospital E&M - Initial | Facility | 273 | 256 | $122.37 | $33K |
| 99214 Office E&M - Established | Office | 114 | 75 | $82.45 | $9,400 |
| 96365 Intravenous Infusion, Hydration | Office | 75 | 22 | $44.67 | $3,351 |
| 96521 Chemotherapy | Office | 64 | 17 | $88.25 | $5,648 |
| 99213 Office E&M - Established | Office | 19 | 19 | $57.46 | $1,092 |
| 99205 Office E&M - New | Office | 18 | 18 | $146.69 | $2,640 |
By year: 2022 $154K for 13,863 services; 2023 $159K for 54,397 services; 2024 $130K for 28,536 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel T Smith prescribed most often to Medicare patients was Azithromycin, with 184 prescriptions and refills. In total Daniel T Smith wrote 1,588 Medicare prescriptions that cost $942K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 184 | 206 | 29 | $5,893 |
| Ethambutol Hcl Generic | 129 | 145 | 22 | $5,083 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 99 | 101 | Under 11 | $405K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 80 | 92 | 21 | $953 |
| Doxycycline Hyclate Generic | 69 | 70 | 24 | $1,632 |
| Cephalexin Generic | 66 | 70 | 25 | $779 |
| Ceftriaxone Ceftriaxone Sodium | 56 | 56 | Under 11 | $1,964 |
| Rifampin Generic | 54 | 70 | 16 | $2,149 |
| Meropenem Generic | 52 | 52 | Under 11 | $11K |
| Penicillin V Potassium Generic | 50 | 82 | 12 | $904 |
| Tivicay Dolutegravir Sodium | 50 | 50 | Under 11 | $115K |
| Moxifloxacin Hcl Generic | 41 | 45 | Under 11 | $8,422 |
| Amoxicillin Generic | 38 | 38 | 14 | $402 |
| Descovy Emtricitabine/Tenofov Alafenam | 34 | 34 | Under 11 | $74K |
| Cefazolin Sodium Generic | 33 | 33 | Under 11 | $766 |
Brand drugs: 249 claims; generic drugs: 1,339 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel T Smith $20.76 ($20.76 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $20.76.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $20.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.